New clonal karyotypic abnormalities acquired following autologous bone marrow transplantation for acute myeloid leukemia do not appear to confer an adverse prognosis (original) (raw)
- Original Article
- Published: 06 March 1998
Relapse of Leukaemia
Bone Marrow Transplantation volume 21, pages 395–399 (1998)Cite this article
- 219 Accesses
- 19 Citations
- Metrics details
Abstract
We undertook a retrospective review of all 76 patients with AML transplanted between August 1986 and March 1995 at our center. All patients received melphalan (140–160 mg/m2), etoposide (60 mg/kg) and total body irradiation. All patients had bone marrow cytogenetic analysis at regular intervals following ABMT. The primary study end point was the development of the new cytogenetic abnormalities. Secondary end points were the development of myelodysplasia (MDS) or AML. Sixty-two of 77 patients were alive at least 6 months post transplant. Cytogenetic abnormalities developed in 7/62 patients (11%) following ABMT. No patients demonstrated MDS or AML. At a median of 30 months after development of the cytogenetic abnormality, only one patient developed features suggestive but not diagnostic of MDS. All seven patients remain alive and leukemia-free up to 70 months after detection of the abnormal clone. There was no increased incidence of cytogenetic abnormalities developing in patients receiving a purged autograft. New cytogenetic abnormalities are frequent following ABMT for AML but do not appear to predict development of myelodysplasia or acute myeloid leukemia. These abnormalities may relate to use of total body radiation as part of the high-dose therapy.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Additional access options:
Similar content being viewed by others
Author information
Authors and Affiliations
- The University of Toronto Autologous Blood and Marrow Transplant Program, The Toronto Hospital and the University of Toronto Cancer Cytogenetics Program, The University of Toronto, Toronto, Canada
KR Imrie, I Dubé, HM Prince, C Girouard, M Crump & A Keating
Authors
- KR Imrie
You can also search for this author inPubMed Google Scholar - I Dubé
You can also search for this author inPubMed Google Scholar - HM Prince
You can also search for this author inPubMed Google Scholar - C Girouard
You can also search for this author inPubMed Google Scholar - M Crump
You can also search for this author inPubMed Google Scholar - A Keating
You can also search for this author inPubMed Google Scholar
Rights and permissions
About this article
Cite this article
Imrie, K., Dubé, I., Prince, H. et al. New clonal karyotypic abnormalities acquired following autologous bone marrow transplantation for acute myeloid leukemia do not appear to confer an adverse prognosis.Bone Marrow Transplant 21, 395–399 (1998). https://doi.org/10.1038/sj.bmt.1701105
- Received: 10 July 1997
- Accepted: 07 October 1997
- Published: 06 March 1998
- Issue Date: 01 February 1998
- DOI: https://doi.org/10.1038/sj.bmt.1701105